Akebia Therapeutics Inc (AKBA)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

245 FIRST STREET CAMBRIDGE, MA 02142

Akebia Therapeutics, Inc. manufactures biopharmaceutical products. The Company develop and distributes novel therapeutics based on the biology of hypoxia inducible factor (HIF) for patients with kidney diseases. Akebia Therapeutics serves customers in the United States.

Data as of 2020-11-22
Market Cap416.272 Million Shares Outstanding144.539 Million Avg 30-day Volume7.906 Million
P/E Ratio-1.0 Dividend Yield EPS-2.96
Price/Sales1.351 Price cash flow ratio10.5 Price free cash flow ratio-2.4
Book Value2.2 Price to Tangible Book3.73 Alpha-0.01
Short Interest Ratio % Short Interest to Float R-squared0.120858
BETA1.81036 52-week High/Low13.71 / 2.09 Stddev0.219446
View SEC Filings from AKBA instead.
Q3 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 3 -100.0% 0 (0.0%) 3 (0.19%) -100.0%
Funds Holding: 159 187 -14.97% 49 (3.22%) 66 (4.28%) -25.76%
13F shares: 100.03 Million 109.991 Million -9.06% 50.47 Million 66.75 Million -24.39%
% Ownership 69.7959 76.9621 -9.31% 35.2154 46.7056 -24.6%
New Positions: 28 47 -40.43% 12 22 -45.45%
Increased Positions 66 76 -13.16% 19 22 -13.64%
Closed Positions 52 13 300.0% 28 4 600.0%
Reduced Positions 42 42 0.0% 13 16 -18.75%
Total Calls 2.183 Million 1.907 Million 14.44% 80.2 Thousand 159.8 Thousand -49.81%
Total Puts 766.154 Thousand 211.805 Thousand 261.73% 165.6 Thousand 18.1 Thousand 814.92%
PUT/CALL Ratio 0.35 0.11 218.18% 2.06 0.11 1772.73%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding AKBA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AKBA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SPELLMAN DAVID A SVP, CFO AND TREASURER

  • Officer
0 2020-06-30 2

GOWEN MAXINE

24,133 2020-06-05 1

SMITH CYNTHIA

37,833 2020-06-05 1

ENYEDY MARK J

31,143 2020-06-05 1

GILMAN STEVEN C

38,864 2020-06-05 1

HEFFERNAN MICHAEL THOMAS

34,886 2020-06-05 1

ADAMS ADRIAN

77,400 2020-06-05 1

ROGERS MICHAEL W

38,629 2020-06-05 1

FAULKINGHAM DELL CCO

73,574 2020-06-01 2

WOLF MYLES

0 2020-04-06 2

HADAS NICOLE R. SVP, CHIEF LEGAL OFFICER

212,756 2020-02-28 1

AMELLO JASON SVP, CFO & TREASURER

144,642 2020-02-28 1

BUTLER JOHN P. CEO AND PRESIDENT

1,308,582 2020-02-28 2

DAHAN MICHEL SVP, CHIEF OPERATING OFFICER

204,960 2020-02-28 1

TUBRIDY KAREN L SVP, CHIEF DEVELOPMENT OFFICER

84,679 2020-02-28 1

BURKE STEVEN KEITH SVP, CHIEF MEDICAL OFFICER

99,000 2020-02-28 1

CANUTE SCOTT A

13,700 2019-06-06 0

MORRISON JODIE POPE

58,619 2019-06-06 0

JAIN RITA SVP, CHIEF MEDICAL OFFICER

  • Officer
96,332 2019-04-11 0

CLAYMAN MICHAEL D.

0 2018-06-14 0

RENAUD RONALD C JR

0 2018-06-14 0

SATTER MUNEER A

0 2018-06-14 0

NASH DUANE

0 2018-06-14 0

WYZGA MICHAEL S

0 2018-06-14 0

MARONI BRADLEY SVP AND CHIEF MEDICAL OFFICER

64,585 2017-02-21 0

DALAL ANUPAM

0 2016-06-16 0

SHALWITZ ROBERT CHIEF MEDICAL OFFICER

  • Officer
0 2014-05-14 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments